Stay updated on Anamorelin HCl in NSCLC-C: Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.
Latest updates to the Anamorelin HCl in NSCLC-C: Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.4 is now shown in the page header, replacing Revision: v3.3.3.SummaryDifference0.0%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a consolidated Locations section listing participating sites across US states, Australia, and Canada. Updated the page revision to v3.3.3.SummaryDifference1%
- Check55 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and may not all be about the study. Page revision label updated to v3.3.2, replacing the previous v3.2.0 wording.SummaryDifference0.1%
- Check62 days agoChange DetectedNotice about government funding lapse and operating status guidance was removed. The page's core study information, including eligibility and outcomes, remains unchanged.SummaryDifference0.3%
- Check77 days agoChange DetectedNo significant additions or deletions were observed. The ROMANA 3 study page content and structure appear unchanged.SummaryDifference0.2%
- Check105 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%
Stay in the know with updates to Anamorelin HCl in NSCLC-C: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.